Abstract
Homocysteine remethylation disorders are rare inherited disorders caused by a deficient activity of the enzymes involved in the remethylation of homocysteine to methionine. The adolescent/adult-onset remethylation disorders are rarely reported. We analyzed the clinical and genetic characteristics of seven cases with adolescent/adult remethylation disorders, including 5 cases of the cobalamin C disease (cblC) and 2 cases of the methylenetetrahydrofolate reductase deficiency. The average onset age was 21.1 (range 14 to 40) years. All patients complained of gait disturbances. Other common symptoms included psychiatric symptoms (5/7) and cognitive decline (4/7). Acute encephalopathy, dysarthria, anorexia, vomiting, ketoacidosis, anemia, cataract, and hand tremor were also observed. The mean total homocysteine in serum when the patients were diagnosed was 94.6 (range 53.1–154.5) mol/L. Electrophysiological studies revealed neuropathy in the lower limbs (6/7). The brain MRI showed reversible altered signal from the dorsal portions of the cerebellar hemispheres (1/7), periventricular hyperintensity (2/7), and delayed/impaired myelination (2/7). The sural nerve biopsy performed in one case showed a modest loss of myelinated fibers. Five patients showed heterozygous mutations of the MMACHC gene, including c.482G>A (5/5), c.609G>A (2/5), and c.658-660delAAG (3/5). Two patients showed heterozygous mutations of the MTHFR gene, including c.698C>A (2/2), c.698C>G (1/2), and c.236+1G>A (1/2). The patients responded well to the treatments with significant improvements. Adolescent/adult-onset remethylation disorders are easily misdiagnosed. We recommend testing the serum homocysteine concentrations in young/adult patients with unexplained neuro-psychotic symptoms. Furthermore, individuals with significantly elevated serum homocysteine concentrations should be further tested by organic acid screening and genetic analysis.
Similar content being viewed by others
References
Huemer M, Diodato D, Schwahn B, Schiff M, Bandeira A, Benoist JF, Burlina A, Cerone R, Couce ML, Garcia-Cazorla A, la Marca G, Pasquini E, Vilarinho L (2017) Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency. J Inherit Metab Dis 40:21–48. https://doi.org/10.1007/s10545-016-9991-4
Keller R, Chrastina P, Pavlikova M, Gouveia S, Ribes A, Kolker S, Blom HJ, Baumgartner MR, Bartl J, Dionisi-Vici C, Gleich F, Morris AA, Kozich V (2019) Newborn screening for homocystinurias: Recent recommendations versus current practice. J Inherit Metab Dis 42:128–139. https://doi.org/10.1002/jimd.12034
Wong D, Tortorelli S, Bishop L, Sellars EA, Schimmenti LA, Gallant N, Prada CE, Hopkin RJ, Leslie ND, Berry SA, Rosenblatt DS, Fair AL, Matern D (2016) Outcomes of four patients with homocysteine remethylation disorders detected by newborn screening. Genet Med 18:162–167. https://doi.org/10.1038/gim.2015.45
Huemer M, Diodato D, Martinelli D, Olivieri G, Blom H, Gleich F, Kolker S, Kozich V, Morris AA, Seifert B, Froese DS, Baumgartner MR, Dionisi-Vici C (2019) Phenotype, treatment practice and outcome in the cobalamin-dependent remethylation disorders and MTHFR deficiency: Data from the E-HOD registry. J Inherit Metab Dis 42:333–352. https://doi.org/10.1002/jimd.12041
Carrillo-Carrasco N, Chandler RJ, Venditti CP (2012) Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management. J Inherit Metab Dis 35:91–102. https://doi.org/10.1007/s10545-011-9364-y
Huemer M, Mulder-Bleile R, Burda P, Froese DS, Suormala T, Zeev BB, Chinnery PF, Dionisi-Vici C, Dobbelaere D, Gokcay G, Demirkol M, Haberle J, Lossos A (2016) Clinical pattern, mutations and in vitro residual activity in 33 patients with severe 5, 10 methylenetetrahydrofolate reductase (MTHFR) deficiency. J Inherit Metab Dis 39:115–124. https://doi.org/10.1007/s10545-015-9860-6
Huemer M, Scholl-Burgi S, Hadaya K, Kern I, Beer R, Seppi K, Fowler B, Baumgartner MR, Karall D (2014) Three new cases of late-onset cblC defect and review of the literature illustrating when to consider inborn errors of metabolism beyond infancy. Orphanet J Rare Dis 9:161. https://doi.org/10.1186/s13023-014-0161-1
Gales A, Masingue M, Millecamps S, Giraudier S, Grosliere L, Adam C, Salim C, Navarro V, Nadjar Y (2018) Adolescence/adult onset MTHFR deficiency may manifest as isolated and treatable distinct neuro-psychiatric syndromes. Orphanet J Rare Dis 13:29. https://doi.org/10.1186/s13023-018-0767-9
Wang X, Yang Y, Li X, Li C, Wang C (2019) Distinct clinical, neuroimaging and genetic profiles of late-onset cobalamin C defects (cb1C): a report of 16 Chinese cases. Orphanet J Rare Dis 14:109. https://doi.org/10.1186/s13023-019-1058-9
Lerner-Ellis JP, Tirone JC, Pawelek PD, Dore C, Atkinson JL, Watkins D, Morel CF, Fujiwara TM, Moras E, Hosack AR, Dunbar GV, Antonicka H, Forgetta V (2006) Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type. Nat Genet 38:93–100. https://doi.org/10.1038/ng1683
Froese DS, Huemer M, Suormala T, Burda P, Coelho D, Gueant JL, Landolt MA, Kozich V, Fowler B, Baumgartner MR (2016) Mutation update and review of severe methylenetetrahydrofolate reductase deficiency. Hum Mutat 37:427–438. https://doi.org/10.1002/humu.22970
Roalf DR, Moberg PJ, Xie SX, Wolk DA, Moelter ST, Arnold SE (2013) Comparative accuracies of two common screening instruments for classification of Alzheimer’s disease, mild cognitive impairment, and healthy aging. Alzheimers Dement 9:529–537. https://doi.org/10.1016/j.jalz.2012.10.001
Li H, Durbin R (2010) Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26:589–595. https://doi.org/10.1093/bioinformatics/btp698
Lin N, Jiang N, Dai Y, Gao J, Wang L (2016) Adult-onset severe methylenetetrahydrofolate reductase deficiency characterized by reversible spastic paraplegia with a novel mutation. Neurol Sci 37:1735–1737. https://doi.org/10.1007/s10072-016-2580-3
Burda P, Schafer A, Suormala T, Rummel T, Burer C, Heuberger D, Frapolli M, Giunta C, Sokolova J, Vlaskova H, Kozich V, Koch HG, Fowler B (2015) Insights into severe 5,10-methylenetetrahydrofolate reductase deficiency: molecular genetic and enzymatic characterization of 76 patients. Hum Mutat 36:611–621. https://doi.org/10.1002/humu.22779
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, Committee ALQA (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424. https://doi.org/10.1038/gim.2015.30
Perna A, Masciullo M, Modoni A, Cellini E, Parrini E, Ricci E, Donati AM, Silvestri G (2018) Severe 5,10-methylenetetrahydrofolate reductase deficiency: a rare, treatable cause of complicated hereditary spastic paraplegia. Eur J Neurol 25:602–605. https://doi.org/10.1111/ene.13557
Lossos A, Teltsh O, Milman T, Meiner V, Rozen R, Leclerc D, Schwahn BC, Karp N, Rosenblatt DS, Watkins D, Shaag A, Korman SH, Heyman SN (2014) Severe methylenetetrahydrofolate reductase deficiency: clinical clues to a potentially treatable cause of adult-onset hereditary spastic paraplegia. JAMA Neurol 71:901–904. https://doi.org/10.1001/jamaneurol.2014.116
Smith SE, Kinney HC, Swoboda KJ, Levy HL (2006) Subacute combined degeneration of the spinal cord in cblC disorder despite treatment with B12. Mol Genet Metab 88:138–145. https://doi.org/10.1016/j.ymgme.2006.02.007
Roze E, Gervais D, Demeret S, Ogier de Baulny H, Zittoun J, Benoist J, Said G, Pierrot-Deseilligny C, Bolgert FJA (2003) Neuropsychiatric disturbances in presumed late-onset cobalamin C disease. Arch Neurol 60:1457–1462. https://doi.org/10.1001/archneur.60.10.1457
Frattini D, Fusco C, Ucchino V, Tavazzi B, Della Giustina E (2010) Early onset methylmalonic aciduria and homocystinuria cblC type with demyelinating neuropathy. Pediatr Neurol 43:135–138. https://doi.org/10.1016/j.pediatrneurol.2010.04.007
Rahmandar MH, Bawcom A, Romano ME, Hamid R (2014) Cobalamin C deficiency in an adolescent with altered mental status and anorexia. Pediatrics 134:e1709–e1714. https://doi.org/10.1542/peds.2013-2711
Tsai AC, Morel CF, Scharer G, Yang M, Lerner-Ellis JP, Rosenblatt DS, Thomas JA (2007) Late-onset combined homocystinuria and methylmalonic aciduria (cblC) and neuropsychiatric disturbance. Am J Med Genet A 143A:2430–2434. https://doi.org/10.1002/ajmg.a.31932
Wan L, Li Y, Zhang Z, Sun Z, He Y, Li R (2018) Methylenetetrahydrofolate reductase and psychiatric diseases. Transl Psychiatry 8:242. https://doi.org/10.1038/s41398-018-0276-6
Gilson RC, Wallis L, Yeh J, Gilson RT (2018) Dementia, diarrhea, desquamating shellac-like dermatitis revealing late-onset cobalamin C deficiency. JAAD Case Rep 4:91–94. https://doi.org/10.1016/j.jdcr.2017.09.016
Rommer PS, Zschocke J, Fowler B, Fodinger M, Konstantopoulou V, Moslinger D, Stogmann E, Suess E, Baumgartner M, Auff E, Sunder-Plassmann G (2017) Manifestations of neurological symptoms and thromboembolism in adults with MTHFR-deficiency. J Neurol Sci 383:123–127. https://doi.org/10.1016/j.jns.2017.10.035
Wang SJ, Yan CZ, Liu YM, Zhao YY (2018) Late-onset cobalamin C deficiency Chinese sibling patients with neuropsychiatric presentations. Metab Brain Dis 33:829–835. https://doi.org/10.1007/s11011-018-0189-3
Almannai M, Marom R, Divin K, Scaglia F, Sutton VR, Craigen WJ, Lee B, Burrage LC, Graham BH (2017) Milder clinical and biochemical phenotypes associated with the c.482G>A (p.Arg161Gln) pathogenic variant in cobalamin C disease: implications for management and screening. Mol Genet Metab 122:60–66. https://doi.org/10.1016/j.ymgme.2017.06.011
Gherasim C, Ruetz M, Li Z, Hudolin S, Banerjee R (2015) Pathogenic mutations differentially affect the catalytic activities of the human B12-processing chaperone CblC and increase futile redox cycling. J Biol Chem 290:11393–11402. https://doi.org/10.1074/jbc.M115.637132
Morel CF, Lerner-Ellis JP, Rosenblatt DS (2006) Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observations. Mol Genet Metab 88:315–321. https://doi.org/10.1016/j.ymgme.2006.04.001
Acknowledgments
We wish to thank all patients for their cooperation in this study and Dr. Jian Wu from MyGenostics Inc. for his excellent technical assistance.
Author information
Authors and Affiliations
Contributions
KC designed the study, performed neurological examinations, collected the clinical data, performed the molecular genetic test and analysis, searched the literature, and wrote the manuscript. ZZ performed neurological examinations. HS performed nerve biopsy and muscle biopsy. QB performed electrophysiological procedures. NL and XG revised the manuscript. JH designed the study and undertook the critical revision of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This study was approved by the Ethical Committee of the Third Hospital of Hebei Medical University and was conducted in accordance with the Declaration of Helsinki.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chang, KJ., Zhao, Z., Shen, HR. et al. Adolescent/adult-onset homocysteine remethylation disorders characterized by gait disturbance with/without psychiatric symptoms and cognitive decline: a series of seven cases. Neurol Sci 42, 1987–1993 (2021). https://doi.org/10.1007/s10072-020-04756-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-020-04756-0